ACST: Acasti PEG Multiple
Acasti Pharma (ACST) automates the search for cardiological formulas through AI modeling and robotics. The business relies on the global sale of proprietary treatments for orphan diseases. The current PEG ratio in the time series on the GURU.Markets chart is fixed at 0.00, which helps assess the balance between price and earnings. The developer's stable academic authority serves as a positive factor for future investments.
Acasti Pharma (ACST) - metric breakdowns and financial figures
Investors use this ratio to determine the fair value of a business by comparing the current P/E multiple with projected earnings growth rates. For Acasti Pharma (ACST), which is optimizing costs through the outsourcing of manufacturing and clinical trials, this calculation reveals hidden capitalization potential, allowing for the identification of fundamental asset undervaluation using the PEG filter for undervalued "rockets."
